Subscribe to Newsletter

Discovery & Development

Discovery & Development Drug Discovery

The FLEET of Hope

| Robert H Cichewicz | 3 min read

Fungal infections and antifungal resistance are a significant problem; here’s one approach to consider

Discovery & Development Drug Discovery

Meet an AI Model that Predicts Teratogenicity

| Jamie Irvine | 3 min read

Researchers demonstrate that complex data analysis paired with artificial intelligence can predict additional causes of Teratogenicity

Discovery & Development Drug Discovery

CRISPR With Caution

| Rob Coker | 3 min read

Deputy editor Rob Coker recalls his trip to the labs of Caszyme, Vilnius, where he spoke with CEO Monika Paule about the potential of genome editing

Discovery & Development Drug Discovery

Addressing Alzheimer’s

| 3 min read

The more we learn about the complexity of Alzheimer’s, the more we need to change the way we treat it

Discovery & Development Drug Discovery

Alzheimer’s Treatment Timeline

| Stephanie Vine | 2 min read

With new drugs showing promise for Alzheimer’s, is the drug development drought over?

Discovery & Development Drug Discovery

Fabulously Interesting

| 6 min read

Sitting Down With… Sharon L Rogers, AmyriAD CEO, Renowned drug developer, 2023 Power Lister, and Olympic figure skating official

Discovery & Development Clinical Trials

Ignaz Semmelweis, We Salute You

| Rob Coker | 4 min read

In the second episode of the We Salute You series, we focus on much maligned Hungarian physician Ignaz Semmelweis

Discovery & Development Drug Discovery

Llamas Versus Dengue

| Stephanie Vine | 3 min read

Why one company is focusing on camelid-derived antibodies to tackle dengue.

Discovery & Development Drug Discovery

Exploring Alzheimer’s in Women

| Jamie Irvine | 2 min read

Studying the link between Alzheimer’s risk, estrogen levels, and menopausal status in women

Discovery & Development Drug Discovery

FDA Approves First OTC Contraceptive

| Jamie Irvine | 2 min read

Perrigo’s Opill receives FDA approval following unanimous support from advisory committees

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register